SanBio Company Limited
TSE:4592.T
1080 (JPY) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 447.226 | 741.614 | 490.509 | 949.543 | 1,174.644 | 3,229.211 | 204.286 |
| Cost of Revenue
| 14.504 | 24.615 | 132.467 | 74.455 | 446.779 | 740.873 | 53.665 | 17.168 | 14.137 | 0 | 0 |
| Gross Profit
| -14.504 | -24.615 | -132.467 | -74.455 | 0.447 | 0.741 | 436.844 | 932.375 | 1,160.507 | 3,229.211 | 204.286 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0.001 | 0.001 | 0.891 | 0.982 | 0.988 | 1 | 1 |
| Reseach & Development Expenses
| 2,849 | 6,118.125 | 4,955.385 | 4,071.641 | 4,327.729 | 3,721.042 | 4,156.101 | 2,058.346 | 1,695.792 | 623.415 | 530.277 |
| General & Administrative Expenses
| 0 | 1,781.183 | 1,665.498 | 1,730.098 | 1,605.566 | 754.492 | 712.79 | 806.257 | 604.095 | 357.048 | 258.251 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,690 | 1,781.183 | 1,665.498 | 1,730.098 | 1,605.566 | 754.492 | 712.79 | 806.257 | 604.095 | 357.048 | 258.251 |
| Other Expenses
| 0 | -2.302 | 0.328 | 0.237 | 493.099 | 950.868 | 680.001 | 0.203 | -18.279 | -1.108 | 0.071 |
| Operating Expenses
| 4,539 | 7,899.308 | 6,620.883 | 5,801.739 | 5,933.295 | 4,475.534 | 4,868.891 | 2,864.603 | 2,299.887 | 980.463 | 788.528 |
| Operating Income
| -4,539 | -7,899.308 | -6,620.884 | -5,801.74 | -5,486.07 | -3,733.919 | -4,378.381 | -1,932.229 | -1,125.243 | 2,248.746 | -584.242 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | -12.267 | -5.035 | -8.926 | -2.035 | -0.958 | 0.696 | -2.86 |
| Total Other Income Expenses Net
| 1,997 | 3,201.865 | 2,060.461 | 2,590.243 | 0.33 | 0.815 | 439.265 | -233.99 | -47.16 | -20.472 | -5.148 |
| Income Before Tax
| -2,542 | -4,697.443 | -4,560.423 | -3,211.497 | -5,156.506 | -2,919.353 | -3,939.117 | -2,166.218 | -1,172.403 | 2,228.276 | -589.39 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | -11.53 | -3.936 | -8.031 | -2.281 | -0.998 | 0.69 | -2.885 |
| Income Tax Expense
| 102 | 862.141 | 117.433 | 174.378 | 1.209 | 1.21 | 1.21 | -330.922 | -184.005 | 492.01 | 0.064 |
| Net Income
| -2,644 | -5,559.584 | -4,677.856 | -3,385.875 | -5,157.716 | -2,920.563 | -3,940.327 | -1,835.296 | -988.397 | 1,736.265 | -589.454 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | -11.533 | -3.938 | -8.033 | -1.933 | -0.841 | 0.538 | -2.885 |
| EPS
| -40.48 | -95.99 | -90.33 | -65.38 | -100.91 | -60.17 | -86.85 | -40.88 | -22.67 | 44.31 | -15.41 |
| EPS Diluted
| -40.48 | -95.99 | -90.33 | -65.38 | -100.91 | -60.17 | -86.85 | -40.88 | -22.67 | 44.31 | -15.41 |
| EBITDA
| -4,525 | -4,648.983 | -4,531.133 | -6,408.792 | -5,059.544 | -2,849.226 | -3,868.032 | -2,126.911 | -1,140.139 | 2,239.591 | -581.441 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | -11.313 | -3.842 | -7.886 | -2.24 | -0.971 | 0.694 | -2.846 |